378 related articles for article (PubMed ID: 23847220)
1. Myelodysplastic syndromes: clinical practice guidelines in oncology.
Greenberg PL; Attar E; Bennett JM; Bloomfield CD; Borate U; De Castro CM; Deeg HJ; Frankfurt O; Gaensler K; Garcia-Manero G; Gore SD; Head D; Komrokji R; Maness LJ; Millenson M; O'Donnell MR; Shami PJ; Stein BL; Stone RM; Thompson JE; Westervelt P; Wheeler B; Shead DA; Naganuma M
J Natl Compr Canc Netw; 2013 Jul; 11(7):838-74. PubMed ID: 23847220
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Greenberg PL; Stone RM; Al-Kali A; Barta SK; Bejar R; Bennett JM; Carraway H; De Castro CM; Deeg HJ; DeZern AE; Fathi AT; Frankfurt O; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Horsfall R; Johnson RA; Juckett M; Klimek VM; Komrokji R; Kujawski LA; Maness LJ; O'Donnell MR; Pollyea DA; Shami PJ; Stein BL; Walker AR; Westervelt P; Zeidan A; Shead DA; Smith C
J Natl Compr Canc Netw; 2017 Jan; 15(1):60-87. PubMed ID: 28040720
[TBL] [Abstract][Full Text] [Related]
3. Management of myelodysplastic syndromes: 2008 update.
Scott BL; Estey E
Oncology (Williston Park); 2008 Nov; 22(12):1344-52. PubMed ID: 19086598
[TBL] [Abstract][Full Text] [Related]
4. Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society.
Meers S; Breems D; Bries G; Delforge M; Graux C; Ravoet C; Selleslag D; Noens L;
Acta Clin Belg; 2013; 68(4):253-62. PubMed ID: 24455794
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Treatment of Myelodysplastic Syndromes: A Review.
Sekeres MA; Taylor J
JAMA; 2022 Sep; 328(9):872-880. PubMed ID: 36066514
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
7. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2012 Jul; 87(7):692-701. PubMed ID: 22696212
[TBL] [Abstract][Full Text] [Related]
9. Evolving therapies for lower-risk myelodysplastic syndromes.
Bewersdorf JP; Zeidan AM
Ann Hematol; 2020 Apr; 99(4):677-692. PubMed ID: 32078008
[TBL] [Abstract][Full Text] [Related]
10. Update on the science of myelodysplastic syndromes.
Ridgeway JA; Fechter L; Murray C; Borràs N
Clin J Oncol Nurs; 2012 Jun; 16 Suppl():9-22. PubMed ID: 22641281
[TBL] [Abstract][Full Text] [Related]
11. [Individualized management and therapy of myelodysplastic syndromes].
Stauder R; Wimazal F; Nösslinger T; Krieger O; Sperr WR; Sill H; Pfeilstöcker M; Valent P
Wien Klin Wochenschr; 2008; 120(17-18):523-37. PubMed ID: 18988005
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment.
Marques FK; Sabino AP
Biomed Pharmacother; 2022 Dec; 156():113905. PubMed ID: 36306593
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with lower-risk myelodysplastic syndromes.
Brunner AM; Leitch HA; van de Loosdrecht AA; Bonadies N
Blood Cancer J; 2022 Dec; 12(12):166. PubMed ID: 36517487
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.
Barzi A; Sekeres MA
Cleve Clin J Med; 2010 Jan; 77(1):37-44. PubMed ID: 20048028
[TBL] [Abstract][Full Text] [Related]
16. Novel therapies in low- and high-risk myelodysplastic syndrome.
Germing U; Schroeder T; Kaivers J; Kündgen A; Kobbe G; Gattermann N
Expert Rev Hematol; 2019 Oct; 12(10):893-908. PubMed ID: 31353975
[No Abstract] [Full Text] [Related]
17. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
[TBL] [Abstract][Full Text] [Related]
18. Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes.
Gore SD; Hermes-DeSantis ER
Cancer Control; 2009 Oct; 16 Suppl():2-10. PubMed ID: 20010512
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
[TBL] [Abstract][Full Text] [Related]
20. British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
Killick SB; Ingram W; Culligan D; Enright H; Kell J; Payne EM; Krishnamurthy P; Kulasekararaj A; Raghavan M; Stanworth SJ; Green S; Mufti G; Quek L; Cargo C; Jones GL; Mills J; Sternberg A; Wiseman DH; Bowen D
Br J Haematol; 2021 Jul; 194(2):267-281. PubMed ID: 34180045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
